Medizinische Universität Graz - Research portal

• Go directly to the nagivation.
• Go directly to the content.

• Print view.
• German.
• Contact.
• Data entry.
• Start.
• Open Access.

Development of an EORTC Quality of Life Group Cervical Cancer Module (QLA-CX) Phase III

Abstract

The aim of this project is to develop a questionnaire module to assess the health related quality of life (QL) of women with cervical cancer in clinical trials. The module will comprise issues pertaining to symtoms of cervical cancer, treatment related issues and any addtiotional demensions of QL specific to cervical cancer not sufficiently covered by the EORTC QLQ-C30 i.e. menopausal symptoms, body image, sexuality, urinary symptoms.

The module will be administered in combination with the EORTC QLQ-C30 in clinical trials with cervical cancer patients where QL is a relevant outcome parameter. The cervical module will be constructed according to the EORTC guidelines for developing questionnaire modules following four phases:

Phase 1: Generation of QL-issues; Phase 2: Operationalisation; Phase 3: Pre-testing;Phase 4: Field-testing.

Keywords

Lebensqualität

Zervixkarzinom

Local Subprojectlead:

Greimel Elfriede Renate

Duration:

15.02.2005-31.12.2006

Type of Research

applied research

Staff

Greimel, Elfriede Renate, Project Leader

MUG Research Units

Department of Obstetrics and Gynaecology

Project partners

Dept. of Gynecological Oncology Radiumhemmet/Karolinska University Hospital, Sweden

Dept of Gynecology/Medical University of Gdansk, Poland

Dept. of Radiology/University Hamburg, Germany

Dept. of Social Medicine/University of Leipzig, Germany

East Kent Gynaecological Oncology Centre/Queen Elisabeth the Queen Mothers Hospital, United Kingdom

Erasmus MC-Daniel den Hoed Cancer Center, Netherlands

Institute of Preventive Medicine/National Taiwan University, Taiwan

Medical Center, Leiden University, Netherlands

National Cancer Center, Korea Quality of Cancer Care Branch, Research Institute, Democratic People's Republic of Korea

NHMRC Clinical Trials Centre/University of Sydney, Australia

Sahlgrenska University Hospital, Sweden

University of Rijeka, Croatia

, United Kingdom

Funded by

European Organisation for Research and Treatment of Cancer (EORTC), Brüssel, Belgium